JP Morgan Conference Generates Blockbuster $350 Million Cell & Gene Therapy Deal Announcement

<span class="legendSpanClass">Deal Targets Growing Multibillion Dollar Global Cell & Gene Therapy Market</span>
Published: Jan. 11, 2022 at 12:33 PM MST

KING OF PRUSSIA, Pa., Jan. 11, 2022 /PRNewswire/ --


Ø  South Korea conglomerate, SK, Inc., and the Center for Breakthrough Medicines announce landmark deal at 40th annual JP Morgan Healthcare Conference

Ø  SK's $350MM investment in the Philadelphia-based Center for Breakthrough Medicines transforms the global cell & gene therapy landscape

Ø  Blockbuster deal solidifies Philadelphia as "Cellicon Valley;" strengthens Philadelphia as a global hub for cell & gene therapy research, development and manufacturing

Ø  Deal sets stage for massive hiring in the Philadelphia region


Ø  This historical deal officially closed yesterday and was announced here.

Interviews Available:

Ø  CBM and SK c-suite executives are available for interviews.

Ø  For more information and to arrange interviews:

John F. Kouten
DeFazio Communications
O - 609-241-7352
M – 908-227-4714

View original content:

SOURCE Center for Breakthrough Medicines

The above press release was provided courtesy of PRNewswire. The views, opinions and statements in the press release are not endorsed by Gray Media Group nor do they necessarily state or reflect those of Gray Media Group, Inc.